|Referral date||01 March 2009|
Cancer reform strategy Batch 3
|Closing date for invited submissions / evidence submission:||18 January 2011|
|1st appraisal committee meeting:||01 January 2100|
|Communications manager:||Alice Law|
|Executive Lead:||Peter Littlejohns|
|Project manager:||Lori Farrar|
|Technical Lead:||Panagiota Vrouchou|
|Others||Department of Health|
|Hywel Dda Local Health Board|
|Welsh Assembly Government|
|Patient/carer groups||Prostate Cancer Charity|
|Professional groups||British Uro-Oncology Group|
|Royal College of Nursing|
|Royal College of Pathologists|
|Royal College of Physicians|
|United Kingdom Oncology Nursing Society|
|Associated Guideline Groups||None|
|Associated Public Health Groups||None|
|Evidence Review Group||National Institute for Health Research Health Technology Assessment Programme|
|Southampton Health Technology Assessment Centre|
|General||Commissioning Support Appraisals Service|
|Department of Health,Social Services and Public Safety for Northern Ireland|
|NHS Quality Improvement Scotland|
|Relevant research groups||MRC Clinical Trials Unit|
|27 April 2011||
NICE has been informed by the manufacturer of dutasteride, GSK, that they have withdrawn their licensing application for the above indication. Therefore this appraisal topic has been suspended and the appraisal committee agenda topic that was due to take place on 14 September 2011 has been cancelled.
NICE will continue to monitor any development and update this webpage if the situation changes.
|21 January 2011||
NICE has re-scheduled the first Appraisal Committee meeting for a number of technology appraisal topics.
In rescheduling these topics we have been careful to maintain our ability to issue timely recommendations.
This appraisal of Dutasteride for reducing the risk of developing prostate cancer is one of the topics that has been identified.
The first appraisal committee discussion will now take place on 14 September 2011. The second committee meeting (if required) will also be rescheduled.
|30 July 2010||
Please note that following on from advice received from the manufacturer, this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin end of October 2010. The deadline for submissions is expectedin approximately mid January 2011.
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance